Evaluation of a reducible disulfide linker for siderophore-mediated delivery of antibiotics
Open Access
- 2 July 2018
- journal article
- research article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 23 (7) , 1025-1036
Abstract
Bacterial iron uptake machinery can be hijacked for the targeted delivery of antibiotics into pathogens by attaching antibiotics to siderophores, iron chelators that are employed by bacteria to obtain this essential nutrient. We synthesized and evaluated Ent–SS–Cipro, a siderophore–antibiotic conjugate comprised of the triscatecholate siderophore enterobactin and the fluoroquinolone antibiotic ciprofloxacin that contains a self-immolative disulfide linker. This linker is designed to be cleaved after uptake into the reducing environment of the bacterial cytoplasm. We show that the disulfide bond of Ent–SS–Cipro is cleaved by reducing agents, including the cellular reductant glutathione, which results in release of the unmodified fluoroquinolone antibiotic. Antibacterial activity assays against a panel of Escherichia coli show that Ent–SS–Cipro exhibits activity against some, but not all, E. coli. This work informs the design of siderophore–antibiotic conjugates, particularly those carrying antibiotics with cytoplasmic targets that require release after uptake into bacterial cells, and indicates that disulfide linkers may not be generally applicable for conjugation strategies of antibiotics.Keywords
Funding Information
- National Institutes of Health (1R01AI114625, 1R21AI126465, P30-ES002109)
- Germany National Academy of Sciences (LPDS 2015-08)
This publication has 59 references indexed in Scilit:
- Synthesis and antibacterial activity of conjugates between norfloxacin and analogues of the siderophore vanchrobactinBioorganic & Medicinal Chemistry, 2013
- Syntheses of Siderophore–Drug Conjugates Using a Convergent Thiol–Maleimide SystemACS Medicinal Chemistry Letters, 2012
- Iron Transport-Mediated Drug Delivery: Practical Syntheses and In Vitro Antibacterial Studies of Tris-Catecholate Siderophore–Aminopenicillin Conjugates Reveals Selectively Potent Antipseudomonal ActivityJournal of the American Chemical Society, 2012
- Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkersBioorganic & Medicinal Chemistry, 2012
- Synthesis and biological properties of conjugates between fluoroquinolones and a N3′′-functionalized pyochelinOrganic & Biomolecular Chemistry, 2011
- The Bacterial Cell EnvelopeCold Spring Harbor Perspectives in Biology, 2010
- Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin “Trojan Horse” antibiotics and synthetic desferridanoxamine-antibiotic conjugatesBioMetals, 2009
- Sideromycins: tools and antibioticsBioMetals, 2009
- Siderophore-Based Iron Acquisition and Pathogen ControlMicrobiology and Molecular Biology Reviews, 2007
- Advances in understanding bacterial outer-membrane biogenesisNature Reviews Microbiology, 2006